Phibro Animal Health Corp... (PAHC)
21.68
0.04 (0.18%)
At close: Mar 27, 2025, 3:59 PM
21.64
-0.20%
Pre-market: Mar 28, 2025, 07:00 AM EDT
Phibro Animal Health Corporation Revenue Breakdown
| Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|
| Vaccines Revenue | 32.03M | 31.99M | 32.92M | 29.73M | 26.22M | 26.2M | 22.77M | 23.02M |
| Vaccines Revenue Growth | +0.14% | -2.85% | +10.75% | +13.39% | +0.06% | +15.08% | -1.07% | n/a |
Revenue by Geography
| Quarter | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 63.23M | 61.45M | 66.93M | 58.01M | 57.3M | 90.15M | 51.41M | 50.48M | 46.44M | 43.22M | 43.42M |
| Asia Pacific Revenue Growth | +2.89% | -8.18% | +15.39% | +1.23% | -36.44% | +75.37% | +1.83% | +8.72% | +7.45% | -0.48% | n/a |
| Emea Revenue | 121.98M | 117.81M | 122.48M | n/a | n/a | 480.1M | 494.6M | 484.15M | 473.25M | 475.94M | 435.41M |
| Emea Revenue Growth | +3.53% | -3.81% | n/a | n/a | n/a | -2.93% | +2.16% | +2.30% | -0.57% | +9.31% | n/a |
| Latin America And Canada Revenue | 247.71M | 219.85M | 191.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Latin America And Canada Revenue Growth | +12.67% | +15.07% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 584.76M | 578.77M | 561.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +1.03% | +3.02% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 76.34M | 65.8M | 74.14M | 58.68M | 62.91M | 68.5M | 52.9M | 57M | 61.54M | 54.96M | 55.5M | 52.43M | 48.38M | 50.07M | 50.7M | 49.03M | 48.38M | 48.43M | 42.4M | 48.23M | 49.49M | 47.52M | 53.2M | 42.3M | 42.94M | 42.95M | 41.4M | 42.58M | 42.98M | 40.99M | 39.6M | 30.65M | 40.87M | 39.19M | 39.5M | 38.78M | 39.8M | 38.3M | 39.88M | 37.3M |
| Selling, General, and Administrative Revenue Growth | +16.02% | -11.25% | +26.34% | -6.73% | -8.15% | +29.49% | -7.19% | -7.38% | +11.97% | -0.97% | +5.85% | +8.38% | -3.37% | -1.25% | +3.40% | +1.36% | -0.12% | +14.22% | -12.09% | -2.55% | +4.16% | -10.68% | +25.76% | -1.48% | -0.03% | +3.75% | -2.76% | -0.94% | +4.84% | +3.52% | +29.22% | -25.02% | +4.30% | -0.79% | +1.85% | -2.54% | +3.90% | -3.97% | +6.94% | n/a |
| Research and Development Revenue | n/a | n/a | 29.19M | n/a | n/a | n/a | 24.39M | n/a | n/a | n/a | 20.83M | n/a | n/a | n/a | 17.76M | n/a | n/a | n/a | 13.74M | n/a | n/a | n/a | 12.09M | n/a | n/a | n/a | 10M | n/a | n/a | n/a | 11.02M | n/a | n/a | n/a | 11.03M | n/a | n/a | n/a | 9.51M | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a |